Endava Ltd (DAVA)vsZepp Health Corp (ZEPP)
DAVA
Endava Ltd
$4.02
-5.41%
TECHNOLOGY · Cap: $229.34M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Endava Ltd generates 187% more annual revenue ($743.90M vs $258.90M). DAVA leads profitability with a -0.4% profit margin vs -15.5%. DAVA earns a higher WallStSmart Score of 43/100 (D).
DAVA
Hold43
out of 100
Grade: D
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DAVA.
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
ROE of -0.5% — below average capital efficiency
Revenue declined 5.9%
Earnings declined 21.4%
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : DAVA
The strongest argument for DAVA centers on PEG Ratio, Price/Book, Altman Z-Score. PEG of 0.43 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : DAVA
The primary concerns for DAVA are Market Cap, Return on Equity, Revenue Growth.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
DAVA profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DAVA scores higher overall (43/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Endava Ltd
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Endava plc provides technology services for clients in the consumer products, healthcare, logistics and retail sectors in Europe, Latin America and North America. The company is headquartered in London, United Kingdom.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?